TrialClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.

Niklas Broman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.